Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017)

Record Type:
Journal Article
Title:
Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017)
Main Title:
Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS)
Authors:
Stein, E.M.
Fathi, A.T.
DiNardo, C.D.
Pollyea, D.A.
Swords, R.T.
Roboz, G.J.
Collins, R.
Sekeres, M.A.
Stone, R.M.
Attar, E.C.
Tosolini, A.
Xu, Q.
Amatangelo, M.
Gupta, I.
Knight, R.D.
de Botton, S.
Tallman, M.S.
Kantarjian, H.M.
Abstract:
Is Part Of:
Leukemia research. Volume 55(2017)Supplement 1
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Issue Display:
Volume 55, Issue 1 (2017)
Year:
2017
Volume:
55
Issue:
1
Issue Sort Value:
2017-0055-0001-0000
Page Start:
S24
Page End:
S25
Publication Date:
2017-04
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0145-2126(17)30151-0 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
439.xml